SCMCI
Petah-Tikva, 14 Kaplan S., Israel
NCT Number: NCT02191722
We believe, that the results of this study will show that children learn from the comic book about their disease, and are now more aware and less frightened about it, and increase their compliance.
Looking for future studies?
Notify Me10 year–18 year
All sexes
Interventional
Not applicable
Petah-Tikva, 14 Kaplan S., Israel
We believe, that the results of this study will show that children learn from the comic book about their disease, and are now more aware and less frightened about it, and increase their compliance. If so, it may promote the use of comic books or other fun educational tool in teaching children various other diseases.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Children with JIA aged 10-18 after parents signed ICF
Exclusion criteria
Parents that do not wanf their children to participate in the study.
Time frame: 2 Years
Time frame: 2 Years
Time frame: 2 years
Rabin Medical Center
Other
Evaluating the Efficacy of a Comic Book as an Educating Tool for Children With Juvenile Idiopathic Arthritis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06546293
Arthritis, Arthritis, Juvenile
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT03092427
Arthritis, Arthritis, Juvenile
Paris, France
View Trial DetailsNCT01500551
Arthritis, Arthritis, Juvenile
Little Rock, Arkansas, United States
View Trial DetailsNCT02840175
Arthritis, Arthritis, Juvenile
Paris, France
View Trial Details